Dr. Cynthia Seow is Professor at the Cumming School of Medicine, University of Calgary working as a Clinician Researcher in Gastroenterology. She completed internal medicine in Australia, then an Inflammatory Bowel Disease (IBD) fellowship along with a MSc in Clinical Epidemiology at the University of Toronto. Her interests include special populations, (pediatric to adult transition, sexual health, preconception and pregnancy health), pharmacokinetics of advanced therapies, and preventive care, specifically, vaccinations in IBD. Dr. Seow is the North American lead for the Global Consensus for the Management of IBD in Pregnancy and lead of the Medications in Pregnancy section; and has been involved in other international IBD pregnancy and IBD pharmacology guidelines. She maintains active research funding, has >150 peer reviewed publications, and is on several journal editorial boards. She is on the Steering Committee for Mentoring in IBD, MILESTONE Canada for IBD fellows, and faculty for MILESTONE USA, and involved in initiatives by Crohns and Colitis Canada.

I have/had an affiliation (financial or otherwise) with a for-profit or not-for-profit organization.
- Member of an advisory board or speakers’ bureau: Janssen, Abbvie, Takeda, Lilly, Ferring, Merck, Pfizer, Organon, Sandoz, Pharmascience, Fresenius Kabi, Amgen, Celltrion, Sanofi, GSK, Biocon.

I intend to make therapeutic recommendations for medications that have not received regulatory approval (ie, “off-label” use of medications).